{"id":396881,"date":"2025-11-22T12:19:12","date_gmt":"2025-11-22T12:19:12","guid":{"rendered":"https:\/\/www.europesays.com\/us\/396881\/"},"modified":"2025-11-22T12:19:12","modified_gmt":"2025-11-22T12:19:12","slug":"new-studies-offer-insight-into-reducing-heart-disease-risk-wral-com","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/396881\/","title":{"rendered":"New studies offer insight into reducing heart disease risk :: WRAL.com"},"content":{"rendered":"<p>\nNew findings presented at the American Heart Association\u2019s Scientific Sessions<br \/>\nare highlighting new efforts to prevent heart disease. <\/p>\n<p>Dr. Nishant Shah, an American Heart Association volunteer and<br \/>\nassociate professor of medicine at Duke University Medical Center, said this<br \/>\nyear\u2019s conference showcases \u201cgroundbreaking technologies\u201d with a growing focus<br \/>\non stopping heart disease before it starts.<\/p>\n<p>\u201cOne of the studies I was excited to see was called the<br \/>\nVesalius-CV trial. That was looking at the impact of a novel cholesterol<br \/>\nlowering medication,\u201d said Shah. <\/p>\n<p>The medication is already on the market, but researchers<br \/>\ntested it in people who have not yet had a heart attack or stroke. Shah<br \/>\nexplained it\u2019s a population group that doesn\u2019t typically get this aggressive treatment<br \/>\nup front.<\/p>\n<p>The physician shared the trial found \u201cprofound reductions\u201d<br \/>\nin cardiovascular events within these patients.<\/p>\n<p>Shah noted the study reinforces the importance of<br \/>\nidentifying cardiovascular risk at every stage, including before someone has had<br \/>\nan event. Prevention efforts also focused on managing obesity, hypertension,<br \/>\nand lifestyle factors, which are all contributing factors to rising rates of heart<br \/>\nattacks in young patients.<\/p>\n<p>\u201cThere are many reasons why younger people are getting heart<br \/>\nattacks,\u201d said Shah. \u201cWe need to be proactive rather than reactive. The science<br \/>\nis moving in that direction and discovering drugs or strategies to lower risk<br \/>\nto avoid early onset heart disease.\u201d<\/p>\n<p>AHA sessions also featured new gene-editing technologies for<br \/>\ncholesterol and alternative forms of available cholesterol therapies, aimed at<br \/>\nbetter prevention. <\/p>\n<p>Other research looked at whether a daily cup of coffee might<br \/>\nprevent abnormal heart rhythms from returning after treatment, but doctors<br \/>\ncaution additional studies are needed.<\/p>\n<p>\u201cA lot of these studies are early in the investigational phases,<br \/>\nso we can\u2019t jump the gun too much. We still need to get more data, understand<br \/>\nthe methodology of these studies, and understand how it will move the clinical<br \/>\nneedle forward,\u201d advised Shah. <\/p>\n<p>For his patients, Shah\u2019s message is simple: there\u2019s exciting<br \/>\nscience in the pipeline, but it needs to be personalized. The physician<br \/>\nencourages patients to review their individual risk of cardiovascular disease<br \/>\nwith their providers to see how these findings might apply to them. <\/p>\n<p>\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"New findings presented at the American Heart Association\u2019s Scientific Sessions are highlighting new efforts to prevent heart disease.&hellip;\n","protected":false},"author":3,"featured_media":396882,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[210,1691,1165,67,132,68],"class_list":{"0":"post-396881","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-health","8":"tag-health","9":"tag-heart-disease","10":"tag-lifestyle","11":"tag-united-states","12":"tag-unitedstates","13":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115593318627631702","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/396881","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=396881"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/396881\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/396882"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=396881"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=396881"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=396881"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}